Congrats to @multiplylabs (YC S16) on their $75M Series B! They build robots that manufacture the world's most complex drugs, including gene therapies and mRNA treatments. AI is speeding up drug discovery, but someone still has to physically make the medicines, and today that work mostly happens by hand. Manual production is slow, vulnerable to contamination, and can cost more than $1 million per dose for some gene therapies. Multiply's robots run that production inside facilities at…